QingSong Health Statistics
Total Valuation
QingSong Health has a market cap or net worth of HKD 14.15 billion. The enterprise value is 15.48 billion.
| Market Cap | 14.15B |
| Enterprise Value | 15.48B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
QingSong Health has 206.37 million shares outstanding. The number of shares has increased by 89.62% in one year.
| Current Share Class | 206.37M |
| Shares Outstanding | 206.37M |
| Shares Change (YoY) | +89.62% |
| Shares Change (QoQ) | +96.19% |
| Owned by Insiders (%) | 45.11% |
| Owned by Institutions (%) | 10.57% |
| Float | 48.36M |
Valuation Ratios
The trailing PE ratio is 293.39.
| PE Ratio | 293.39 |
| Forward PE | n/a |
| PS Ratio | 10.36 |
| PB Ratio | -11.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 143.91 |
| P/OCF Ratio | 142.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 203.98, with an EV/FCF ratio of 157.51.
| EV / Earnings | 175.65 |
| EV / Sales | 11.34 |
| EV / EBITDA | 203.98 |
| EV / EBIT | 218.99 |
| EV / FCF | 157.51 |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | 23.51 |
| Debt / FCF | 18.16 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -5.75% |
| Revenue Per Employee | 7.00M |
| Profits Per Employee | 452,063 |
| Employee Count | 195 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, QingSong Health has paid 2.84 million in taxes.
| Income Tax | 2.84M |
| Effective Tax Rate | 3.12% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,621,008 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, QingSong Health had revenue of HKD 1.37 billion and earned 88.15 million in profits. Earnings per share was 0.23.
| Revenue | 1.37B |
| Gross Profit | 437.74M |
| Operating Income | 70.70M |
| Pretax Income | 90.99M |
| Net Income | 88.15M |
| EBITDA | 71.06M |
| EBIT | 70.70M |
| Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has 448.08 million in cash and 1.78 billion in debt, giving a net cash position of -1.34 billion or -6.48 per share.
| Cash & Cash Equivalents | 448.08M |
| Total Debt | 1.78B |
| Net Cash | -1.34B |
| Net Cash Per Share | -6.48 |
| Equity (Book Value) | -1.24B |
| Book Value Per Share | -15.48 |
| Working Capital | -1.27B |
Cash Flow
In the last 12 months, operating cash flow was 98.97 million and capital expenditures -669,522, giving a free cash flow of 98.30 million.
| Operating Cash Flow | 98.97M |
| Capital Expenditures | -669,522 |
| Free Cash Flow | 98.30M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 32.06%, with operating and profit margins of 5.18% and 6.46%.
| Gross Margin | 32.06% |
| Operating Margin | 5.18% |
| Pretax Margin | 6.67% |
| Profit Margin | 6.46% |
| EBITDA Margin | 5.20% |
| EBIT Margin | 5.18% |
| FCF Margin | 7.20% |
Dividends & Yields
QingSong Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -89.62% |
| Shareholder Yield | -89.62% |
| Earnings Yield | 0.62% |
| FCF Yield | 0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QingSong Health has an Altman Z-Score of -2.18 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.18 |
| Piotroski F-Score | 4 |